FDA warns about unapproved medications from a Canadian supplier

.

FDA warns about unapproved medications from a Canadian supplier

The U. S. Food & Drug Administration (FDA) has warned more than 350 medical practices that they might have received unapproved, counterfeit or unsafe medications from a Canadian supplier.

The federal food and drugs regulator said that the medications, including unapproved variants of Botox, could harm patients as they could be counterfeit or contaminated.

The foreign supplier who allegedly supplied the unapproved medications to the U. S. medical practices is operated by Canada Drugs, which is also called Quality Specialty Products (QSP), QP Medical or Bridgewater Medical.

In the letter written to the medical practices, the federal agency said, "FDA is very concerned that products distributed by these suppliers may cause harm to patients, because they may be unsafe or ineffective."

The FDA also warned doctors about purchasing drugs from any source other than pharmacies licensed by the U. S. authorities.

Dr. Peter B. Fodor, a plastic surgeon and an expert on Botox, also warned that using a non-FDA approved Botox could be very dangerous.

This is the fifth warning issued by the FDA this year about a foreign supplier supplying unapproved medications.

 


Latest News

Debbie Wasserman Schultz steps down as head of DNC
Wild fire continues to spread in Santa Clarita area
Chinese Currency Faces Increasing Pressure
Crude Futures Remain Close to Two Month Low as Over Supply Concerns Intensify
Reportedly Verizon is Expected to Acquire Yahoo for $4.8 Billion
China’s Economic Growth in the Second Quarter Remains Steady but not without a P
Several Former and Current Fox News Female Workers Talk about their Harassment E
Hillary Clinton picksTim Kaine as running mate
Jerry Brown
Southwest Airlines
Unemployment Rate in California Climbs for First Time in Almost Six Years
Hershey Trust is Close to Reaching Tentative Settlement with Pennsylvania Attorn